Design and evaluation of transdermal films of lornoxicam

International Journal of Pharma and Bio Sciences

Volumn 2, Issue 2, 2011, Pages 54-62

  Kavitha, K ^a   Rajendra, More Mangesh ^a  

^a BHARATHI COLLEGE OF PHARMACY   (India)

Author keywords

Hydroxypropyl methyl cellulose; Lornoxicam; Nsaid; Skin permeation; Solvent evaporation technique; Transdermal patch, etc

Indexed keywords

DICHLOROMETHANE; ETHYL CELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; LORNOXICAM; MACROGOL; METHANOL; PENETRATION ENHANCING AGENT; POLYSORBATE 80; SOLVENT;

ARTICLE; CONTROLLED STUDY; DIFFUSION; DRUG DESIGN; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; EVAPORATION; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; MOISTURE; PHYSICAL CHEMISTRY; TENSILE STRENGTH; TRANSDERMAL PATCH;

EID: 84855512434     PISSN: None     EISSN: 09756299     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. I Sarath Chandiran, T Sivakumar, B Pavankumar, Preparation and evaluation of aceclofenac loaded biodegradable microspheres. Int J Pharm Biomed Res, 1(1): 19-23, (2010).
2. Kshirsagar NA, Drug Delivery Systems. Indian Journal of Pharmacology, 32:S54-S61, (2000).
3. Gupta JRD, Irschhiaya R, Garud N, Priyanka Tripathi, Prashant Dubey, Patel JR, Formulation and evaluation of matrix type transdermal patches of Glibenclamide. Int J Pharm Sci Drug Res, 1: 46-50, (2009).
4. Vyas SP, Khar RK, Controlled drug delivery concepts and advances, 1st Edn, New Delhi: Vallabh Prakashan: 411-47, (2002)
5. Sanap GS, Dama GY, Hande AS, Karpe SP, Nalawade SV, Kakade RS, et al., Preparation of transdermal monolithic systems of indapamide by solvent casting method and the use of vegetable oils as permeation enhancer. Int J Green Pharm, 2: 129-33, (2008).
6. Patel RP, Patel G, Baria A, Formulation and evaluation of transdermal patch of aceclofenac. Int J Drug Deliv, 1: 41-51, (2009).
7. Devi KV, Saisivam S, Maria GR, Deepti PU, Design and evaluation of matrix diffusion controlled transdermal patches of verapamil hydrochloride. Drug Dev Ind Pharm, 29(5): 495-503, (2003).
8. Sheth SK, Patel SJ, Shukla JB, Formulation and Evaluation of Taste Masked Oral Disintegrating Tablet of Lornoxicam. International Journal of Pharma and Bio Sciences, 2: 1-9, (2010).
9. Rajesh S Jadon, Swadesh Nayak, Sabita Amlan, Vikas Deep Vaidya, Prashant Khemariya, Sandip Sumbhate, et al., Taste masking of Lornoxicam by polymer carrier system and formulation of oral disintegrating tablets. International Journal of Drug Delivery, 1: 27-31, (2009).
10. Julia A, Balfour AF, Barradell LB, Lornoxicam: A Review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions. Drugs, 51(4): 639-57, (1996).
11. Welte SR, Rabbeseda X, Lornoxicam, a new potent NSAID with improved tolerability profile. Drugs of Today, 36(1): 55-76, (2000).
12. Balfour JA, Fitton A, Barradell LB, Lornoxicam. A review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions. Drugs, 51(4): 639-57, (1996).
13. Prasad Byrav DS, Medhi B, Prakash A, Patyar S, Wadhwa S, Lornoxicam: a Newer NSAID. IJPMR, 20(1): 27-31, 2009.
14. Shivakumar HN, Jamakandi VG, Mulla JS, Vinay BL, Formulation, characterization and evaluation of matrixtype transdermal patches of a model antihypertensive drug. Asian J Pharm, 3: 59-64, (2009).
15. Ubaidulla U, Reddy MVS, Ruckmani K, Ahmad FJ, Khar RK. Transdermal therapeutic system of carvedilol: effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics. AAPS PharmSciTech, 8(1): E13-20, (2007).
16. Rao YM, Gannu R, Vishnu YV and Kishan V, Development of nitrendipine transdermal patches for in vitro and ex vivo characterization. Curr Drug Deliv, 4: 69-76, (2007).
17. Murthy TEGK, Kishore VS, Effect of casting solvent on permeability of antihypertensive drugs through ethyl cellulose films. J Sci Ind Res, 67: 147-50, (2008).
18. Patel HJ, Patel JS, Desai BG, Patel KD, Design and evaluation of amlodipine besilate transdermal patches containing film former. Int J Pharma Res Dev, 7: 1-12, (2009).
19. .Murthy TEGK and Kishore VS, Effect of casting solvent and polymer on permeability of propranolol hydrochloride through membrane controlled transdermal drug delivery system. Indian J Pharm Sci, 69(5): 646-50, (2007).
20. Subramanian K, Sathyapriya LS, Jayaprakash S, Prabhu RS, Abirami A, Madhumitha B et al. An Approach to the formulation and evaluation of transdermal DDS of isoxsuprine HCl. Int J Pharm Sci Tech, 1(1): 22-8, (2008).
21. Sankar V, Johnson DB, Sivanand V, Ravichandran V, Raghuraman, S, Velrajan G et al., Design and evaluation of nifedipine transdermal patches. Indian J Pharm Sci, 65(5): 510-515, (2003).
22. Shinde AJ, Garala KC, More HN, Development and characterization of transdermal therapeutics system of tramadol hydrochloride. Asian J Pharm, 2: 265-69, (2008).
23. Pandit V, Khanum A, Bhaskaran S, Banu V, Formulation and evaluation of transdermal films for the treatment of overactive bladder. Int J Pharm Tech Res, 1(3): 799-804, (2009).
24. Kulkarni RV, Mutalik S, Hiremath D, Effect of plasticizers on the permeability and mechanical properties of eudragit films for transdermal application. Ind J Pharm Sci, 64(1): 28-31, (2002).
25. Rao V, Mamatha T, Mukkanti K and Ramesh. Transdermal drug delivery system for atomoxetine hydrochloride- in vitro and ex vivo evaluation. Current Trends in Biotechnology and Pharmacy, 3(2): 188-96, (2009).
26. Satturwar PM, Fulzele SV, Dorle AK, Evaluation of polymerized rosin for the formulation and development of transdermal drug delivery system: A Technical Note. AAPS PharmSciTech, 6(4): E649-54, (2005).